Signal transducer and activator of transcription 3 pathway mediates genipin-induced apoptosis in U266 multiple myeloma cells

Journal of Cellular Biochemistry

Volumn 112, Issue 6, 2011, Pages 1552-1562

  Kim, Sung Hoon ^a   Lee, Jang Choon ^a   Ahn, Kwang Seok ^a   Jeong, Soo Jin ^a   Jung, Ji Hoon ^a   Kwon, Tae Rin ^a   Rhee, Yun Hee ^a   Kim, Sun Hee ^a   Kim, Si Young ^b   Yoon, Hwi Joong ^b   Zhu, Shudong ^c   Chen, Chang Yan ^c  

^a Kyung Hee University   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

bortezomib; genipin; multiple myeloma; paclitaxel; STAT3; thalidomide

Indexed keywords

BORTEZOMIB; CYCLIN D1; GENIPIN; JANUS KINASE 1; PACLITAXEL; PERVANADATE; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN TYROSINE PHOSPHATASE SHP 1; STAT3 PROTEIN; SURVIVIN; THALIDOMIDE; VASCULOTROPIN;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG ACTIVITY; DRUG MECHANISM; DRUG POTENTIATION; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; NICK END LABELING; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; BORONIC ACIDS; CELL LINE, TUMOR; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HUMANS; IN SITU NICK-END LABELING; IRIDOID GLYCOSIDES; MULTIPLE MYELOMA; PYRAZINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

GARDENIA;

EID: 79954521502     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23077     Document Type: Article

References (47)

1. Aggarwal BB, Sethi G, Ahn KS, Sandur SK, Pandey MK, Kunnumakkara AB, Sung B, Ichikawa H,. 2006. Targeting signal-transducer-and-activator-of- transcription-3 for prevention and therapy of cancer: modern target but ancient solution. Ann N Y Acad Sci 1091: 151-169. (Pubitemid 47092233)
2. Ahn KS, Sethi G, Sung B, Goel A, Ralhan R, Aggarwal BB,. 2008. Guggulsterone, a farnesoid X receptor antagonist, inhibits constitutive and inducible STAT3 activation through induction of a protein tyrosine phosphatase SHP-1. Cancer Res 68: 4406-4415.
3. Bowman T, Garcia R, Turkson J, Jove R,. 2000. STATs in oncogenesis. Oncogene 19: 2474-2488. (Pubitemid 30339203)
4. Brenner H, Gondos A, Pulte D,. 2008. Recent major improvement in long-term survival of younger patients with multiple myeloma. Blood 111: 2521-2526.
5. Brierley MM, Fish EN,. 2005. Stats: multifaceted regulators of transcription. J Interferon Cytokine Res 25: 733-744. (Pubitemid 43071210)
6. Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C, Darnell JE Jr., 1999. Stat3 as an oncogene. Cell 98: 295-303. (Pubitemid 29380565)
7. Buettner R, Mora LB, Jove R,. 2002. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin Cancer Res 8: 945-954. (Pubitemid 35177340)
8. Catlett-Falcone R, Landowski TH, Oshiro MM, Turkson J, Levitzki A, Savino R, Ciliberto G, Moscinski L, Fernandez-Luna JL, Nunez G, Dalton WS, Jove R,. 1999. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 10: 105-115. (Pubitemid 29077388)
9. Cavo M,. 2006. Proteasome inhibitor bortezomib for the treatment of multiple myeloma. Leukemia 20: 1341-1352. (Pubitemid 44084044)
10. Chang HM, and, But PPH,. (1987) Pharmacology and applications of chinese materia medica. World Scientific Publishing, Singapore 1005.
11. Chang WC, Lin YL, Lee MJ, Shiow SJ, Wang CJ,. 1996. Inhibitory effect of crocetin on benzo(a)pyrene genotoxicity and neoplastic transformation in C3H10T1/2 cells. Anticancer Res 16: 3603-3608.
12. Epling-Burnette PK, Liu JH, Catlett-Falcone R, Turkson J, Oshiro M, Kothapalli R, Li Y, Wang JM, Yang-Yen HF, Karras J, Jove R, Loughran TP Jr., 2001. Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J Clin Invest 107: 351-362.
13. Feinman R, Koury J, Thames M, Barlogie B, Epstein J, Siegel DS,. 1999. Role of NF-kappaB in the rescue of multiple myeloma cells from glucocorticoid-induced apoptosis by bcl-2. Blood 93: 3044-3052. (Pubitemid 29200797)
14. Gay F, Palumbo A,. 2010. Multiple myeloma: management of adverse events. Med Oncol 27: 646-653.
15. Haematology, UmfBCfSi. 2001. Diagnosis and management of multiple myeloma. Br J Haematol 115: 522-540.
16. Hallek M, Bergsagel PL, Anderson KC,. 1998. Multiple myeloma: increasing evidence for a multistep transformation process. Blood 91: 3-21. (Pubitemid 28018724)
17. Han Y, Amin HM, Franko B, Frantz C, Shi X, Lai R,. 2006. Loss of SHP1 enhances JAK3/STAT3 signaling and decreases proteosome degradation of JAK3 and NPM-ALK in ALK+ anaplastic large-cell lymphoma. Blood 108: 2796-2803.
18. Hong HY, Kim BC,. 2007. Mixed lineage kinase 3 connects reactive oxygen species to c-Jun NH2-terminal kinase-induced mitochondrial apoptosis in genipin-treated PC3 human prostate cancer cells. Biochem Biophys Res Commun 362: 307-312.
19. Ihle JN,. 1996. STATs: signal transducers and activators of transcription. Cell 84: 331-334. (Pubitemid 26058558)
20. Inoue T, Suzuki Y, Mizuno K, Nakata K, Yoshimaru T, Ra C,. 2009. SHP-1 exhibits a pro-apoptotic function in antigen-stimulated mast cells: positive regulation of mitochondrial death pathways and negative regulation of survival signaling pathways. Mol Immunol 47: 222-232.
21. Kannappan R, Yadav VR, Aggarwal BB,. 2010. {Gamma}-tocotrienol but not {gamma}-tocopherol blocks STAT3 cell signaling pathway through induction of protein-tyrosine phosphatase SHP-1 and sensitizes tumor cells to chemotherapeutic agents. J Biol Chem 285: 33520-33528.
22. Kim BC, Kim HG, Lee SA, Lim S, Park EH, Kim SJ, Lim CJ,. 2005. Genipin-induced apoptosis in hepatoma cells is mediated by reactive oxygen species/c-Jun NH2-terminal kinase-dependent activation of mitochondrial pathway. Biochem Pharmacol 70: 1398-1407. (Pubitemid 41383476)
23. Kim LC, Song L, Haura EB,. 2009. Src kinases as therapeutic targets for cancer. Nat Rev Clin Oncol 6: 587-595.
24. Koo HJ, Lim KH, Jung HJ, Park EH,. 2006. Anti-inflammatory evaluation of gardenia extract, geniposide and genipin. J Ethnopharmacol 103: 496-500.
25. Laubach JP, Mitsiades CS, Mahindra A, Schlossman RL, Hideshima T, Chauhan D, Carreau NA, Ghobrial IM, Raje N, Munshi NC, Anderson KC, Richardson PG,. 2009. Novel therapies in the treatment of multiple myeloma. J Natl Compr Canc Netw 7: 947-960.
26. Lima EG, Tan AR, Tai T, Marra KG, DeFail A, Ateshian GA, Hung CT,. 2009. Genipin enhances the mechanical properties of tissue-engineered cartilage and protects against inflammatory degradation when used as a medium supplement. J Biomed Mater Res A 91: 692-700.
27. Ma Z, Otsuyama K, Liu S, Abroun S, Ishikawa H, Tsuyama N, Obata M, Li FJ, Zheng X, Maki Y, Miyamoto K, Kawano MM,. 2005. Baicalein, a component of Scutellaria radix from Huang-Lian-Jie-Du-Tang (HLJDT), leads to suppression of proliferation and induction of apoptosis in human myeloma cells. Blood 105: 3312-3318.
28. Minnema MC, van der Spek E, van de Donk NW, Lokhorst HM,. 2010. New developments in the treatment of patients with multiple myeloma. Neth J Med 68: 24-32.
29. Mitsiades CS, Ocio EM, Pandiella A, Maiso P, Gajate C, Garayoa M, Vilanova D, Montero JC, Mitsiades N, McMullan CJ, Munshi NC, Hideshima T, Chauhan D, Aviles P, Otero G, Faircloth G, Mateos MV, Richardson PG, Mollinedo F, San-Miguel JF, Anderson KC,. 2008. Aplidin, a marine organism-derived compound with potent antimyeloma activity in vitro and in vivo. Cancer Res 68: 5216-5225.
30. Nam KN, Choi YS, Jung HJ, Park GH, Park JM, Moon SK, Cho KH, Kang C, Kang I, Oh MS, Lee EH,. 2010. Genipin inhibits the inflammatory response of rat brain microglial cells. Int Immunopharmacol 10: 493-499.
31. Napoleone E, Zurlo F, Latella MC, Amore C, Di Santo A, Iacoviello L, Donati MB, Lorenzet R,. 2009. Paclitaxel downregulates tissue factor in cancer and host tumour-associated cells. Eur J Cancer 45: 470-477.
32. Nielsen M, Kaestel CG, Eriksen KW, Woetmann A, Stokkedal T, Kaltoft K, Geisler C, Ropke C, Odum N,. 1999. Inhibition of constitutively activated Stat3 correlates with altered Bcl-2/Bax expression and induction of apoptosis in mycosis fungoides tumor cells. Leukemia 13: 735-738. (Pubitemid 29243625)
33. Ocio EM, Maiso P, Chen X, Garayoa M, Alvarez-Fernandez S, San-Segundo L, Vilanova D, Lopez-Corral L, Montero JC, Hernandez-Iglesias T, de Alava E, Galmarini C, Aviles P, Cuevas C, San-Miguel JF, Pandiella A,. 2009. Zalypsis: a novel marine-derived compound with potent antimyeloma activity that reveals high sensitivity of malignant plasma cells to DNA double-strand breaks. Blood 113: 3781-3791.
34. Oka T, Ouchida M, Koyama M, Ogama Y, Takada S, Nakatani Y, Tanaka T, Yoshino T, Hayashi K, Ohara N, Kondo E, Takahashi K, Tsuchiyama J, Tanimoto M, Shimizu K, Akagi T,. 2002. Gene silencing of the tyrosine phosphatase SHP1 gene by aberrant methylation in leukemias/lymphomas. Cancer Res 62: 6390-6394. (Pubitemid 35364092)
35. Ono M, Ishimatsu N, Masuoka C, Yoshimitsu H, Tsuchihashi R, Okawa M, Kinjo J, Ikeda T, Nohara T,. 2007. Three new monoterpenoids from the fruit of Genipa americana. Chem Pharm Bull (Tokyo) 55: 632-634. (Pubitemid 46570845)
36. Pandey MK, Sung B, Ahn KS, Aggarwal BB,. 2009. Butein suppresses constitutive and inducible signal transducer and activator of transcription (STAT) 3 activation and STAT3-regulated gene products through the induction of a protein tyrosine phosphatase SHP-1. Mol Pharmacol 75: 525-533.
37. Park J, Ayyappan V, Bae EK, Lee C, Kim BS, Kim BK, Lee YY, Ahn KS, Yoon SS,. 2008. Curcumin in combination with bortezomib synergistically induced apoptosis in human multiple myeloma U266 cells. Mol Oncol 2: 317-326.
38. Sandur SK, Pandey MK, Sung B, Aggarwal BB,. 2010. 5-hydroxy-2-methyl-1,4- naphthoquinone, a vitamin K3 analogue, suppresses STAT3 activation pathway through induction of protein tyrosine phosphatase, SHP-1: potential role in chemosensitization. Mol Cancer Res 8: 107-118.
39. Sharma SV, Gajowniczek P, Way IP, Lee DY, Jiang J, Yuza Y, Classon M, Haber DA, Settleman J,. 2006. A common signaling cascade may underlie "addiction" to the Src, BCR-ABL, and EGF receptor oncogenes. Cancer Cell 10: 425-435. (Pubitemid 44693471)
40. Shuai K, Stark GR, Kerr IM, Darnell JE Jr., 1993. A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma. Science 261: 1744-1746. (Pubitemid 23332925)
41. Somani AK, Bignon JS, Mills GB, Siminovitch KA, Branch DR,. 1997. Src kinase activity is regulated by the SHP-1 protein-tyrosine phosphatase. J Biol Chem 272: 21113-21119. (Pubitemid 27373970)
42. Tu Y, Renner S, Xu F, Fleishman A, Taylor J, Weisz J, Vescio R, Rettig M, Berenson J, Krajewski S, Reed JC, Lichtenstein A,. 1998. BCL-X expression in multiple myeloma: possible indicator of chemoresistance. Cancer Res 58: 256-262. (Pubitemid 28047064)
43. Woetmann A, Nielsen M, Christensen ST, Brockdorff J, Kaltoft K, Engel AM, Skov S, Brender C, Geisler C, Svejgaard A, Rygaard J, Leick V, Odum N,. 1999. Inhibition of protein phosphatase 2A induces serine/threonine phosphorylation, subcellular redistribution, and functional inhibition of STAT3. Proc Natl Acad Sci U S A 96: 10620-10625. (Pubitemid 29442193)
44. Yu CL, Meyer DJ, Campbell GS, Larner AC, Carter-Su C, Schwartz J, Jove R,. 1995. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 269: 81-83.
45. Yu H, Jove R,. 2004. The STATs of cancer-new molecular targets come of age. Nat Rev Cancer 4: 97-105. (Pubitemid 38198738)
46. Zhang CY, Parton LE, Ye CP, Krauss S, Shen R, Lin CT, Porco JA Jr, Lowell BB,. 2006. Genipin inhibits UCP2-mediated proton leak and acutely reverses obesity- and high glucose-induced beta cell dysfunction in isolated pancreatic islets. Cell Metab 3: 417-427. (Pubitemid 43811776)
47. Zhou T, Zhao W, Fan G, Chai Y, Wu Y,. 2007. Isolation and purification of iridoid glycosides from Gardenia jasminoides Ellis by isocratic reversed-phase two-dimensional preparative high-performance liquid chromatography with column switch technology. J Chromatogr B Analyt Technol Biomed Life Sci 858: 296-301. (Pubitemid 47513604)